Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
QuintilesIMS
Chinese Patent Office
Argus Health
Daiichi Sankyo
Julphar
Federal Trade Commission
Citi
Cerilliant

Generated: January 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Defactinib

« Back to Dashboard

US Patents for Defactinib

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Defactinib ➤ Try a Free Trial Sulfonyl amide derivatives for the treatment of abnormal cell growth Pfizer Inc (New York, NY) ➤ Try a Free Trial
Defactinib ➤ Try a Free Trial Sulfonyl amide derivatives for the treatment of abnormal cell growth Pfizer Inc (New York, NY) ➤ Try a Free Trial
Defactinib ➤ Try a Free Trial Sulfonyl amide derivatives for the treatment of abnormal cell growth ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Defactinib

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
Defactinib Argentina 066125 2027-04-18 ➤ Try a Free Trial
Defactinib Australia 2008240359 2027-04-18 ➤ Try a Free Trial
Defactinib Brazil PI0810411 2027-04-18 ➤ Try a Free Trial
Defactinib Canada 2684447 2027-04-18 ➤ Try a Free Trial
Defactinib Chile 2008001076 2027-04-18 ➤ Try a Free Trial
Defactinib China 101678215 2027-04-18 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Accenture
Argus Health
Chinese Patent Office
Moodys
Queensland Health
Cerilliant
Boehringer Ingelheim
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: